Current Report Filing (8-k)
November 13 2020 - 10:38AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
November 12, 2020
ALLIED
HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
0-19266
|
25-1370721
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices)
|
63110
(Zip Code)
|
Registrant’s telephone number, including area code
|
(314) 771-2400
|
|
Not applicable
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging Growth Company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section
12(b) of the Act:
Title of Each Class
|
Trading Symbol
|
Name of Each Exchange on Which Registered
|
Common Stock, $.01
|
AHPI
|
The NASDAQ Stock Market, LLC
|
ITEM 5.07. Submission of Matters
to a Vote of Security Holders.
The annual meeting of the stockholders
of Allied Healthcare Products, Inc. (the “Company”) was held on November 12, 2020. Proxies were solicited pursuant
to Regulation 14A of the Securities Exchange Act of 1934. There was no solicitation in opposition to management’s nominees
for Directors. The voting results are noted below.
ELECTION OF DIRECTORS
All nominees for Directors were elected with the following votes
cast:
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
Susan E. Deuser
|
|
1,330,798.79
|
|
9,033.09
|
|
1,751,248.00
|
Judith T. Graves
|
|
1,330,009.79
|
|
9,822.09
|
|
1,751,248.00
|
Joseph E. Root
|
|
1,329,034.61
|
|
10,797.27
|
|
1,751,248.00
|
Earl R. Refsland
|
|
1,328,781.61
|
|
11,050.27
|
|
1,751,248.00
|
John D. Weil
|
|
1,327,351.61
|
|
12,480.27
|
|
1,751,248.00
|
Agenda Item 2, concerning the ratification
of the appointment of RubinBrown LLP as the Company’s independent registered public accounting firm for fiscal 2021 was approved
by the stockholders with the following votes cast:
For
|
|
|
Against
|
|
|
Abstain
|
|
|
3,012,210.68
|
|
|
|
66,402.40
|
|
|
|
12,466.00
|
|
Agenda Item 3, an advisory (non-binding)
vote to approve our executive compensation was approved by the stockholders with the following votes cast:
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
1,312,922.88
|
|
21,209.00
|
|
5,700.00
|
|
1,751,248.00
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
ALLIED HEALTHCARE PRODUCTS, INC.
|
|
|
|
|
|
|
Date: November 13, 2020
|
By:
|
/s/ Daniel C. Dunn
|
|
|
Daniel C. Dunn
|
|
|
Chief Financial Officer
|
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Sep 2023 to Sep 2024